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Cystic Fibrosis
India Hutchison BSN, RN, CCRN
Otterbein University, Westerville, Ohio

What is Cystic
Fibrosis (CF)?
o

o

o

o

Pathophysiological Processes
Signs & Symptoms

CF is an autosomal recessive
inherited disease (McCance et al.,
2019).
Result of dysfunctional epithelial
chloride ion transport (McCance et
al., 2019).
Mainly diagnosed in infancy
(Turcios, 2020).
More than 75 percent of people
with CF are diagnosed by age 2
(Cystic Fibrosis Foundation, n.d.).

Underlying Pathophysiology
o

o
o
o
o

Cross section of
IW>t'mal ai1Way

Why Cystic Fibrosis?
o

o

o

o

o

o

Affects 1 in every 3500
Caucasian births (Karrar et
al., 2022).
Affects approximately 30,000
people in the U.S. and
80,000 worldwide (Karrar et al.,
2022).
Patients require support from
healthcare services from
diagnosis onwards (Keogh et
al., 2017).
Although treatment has become
more targeted and the average life
expectancy has increased in recent
years, no cure has been discovered
(Keogh et al., 2017).
The cause of death is almost always
respiratory failure. (Keogh et al.,
2017).
Multisystem involvement results in
a frequent requirement of anesthesia
for surgical procedures (May et al.,
2019).

o

o
o
o
o

Begins with a positive newborn
screening, most commonly due
to abnormal levels of pancreatic
enzyme precursor immunoreactive
trypsinogen (Trucios, 2020).
Definitive diagnostic tool is Sweat
Testing Technique (Karrar et al.,
2022).
Measurement of the chloride and
sodium concentration of sweat
(Karrar et al., 2022).
Usually performed 48 hours after
birth (Turcios, 2020).
Chloride levels begin to increase 24
hours after birth (Karrar et al.,
2022).
A very high concentration of
chloride is diagnostic for Cystic
Fibrosis (Karrar et al., 2022).

Symptoms and severity vary greatly from person to
person; therefore, treatment plans are highly individualized (Cystic
Fibrosis Foundation, n.d.).
As there is no cure, treatment for CF centers around symptom
management (Keogh et al., 2017).
According to the Cystic Fibrosis Foundation (n.d.), the
following treatments are most common:
o

o
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o
o
o
o
o
o

Chest physiotherapy to loosen and clear mucus
accumulation in the airway.
Bronchodilators to maximize airflow into the
lungs.
Mucolytic agents and hypertonic saline
nebulizers to thin secretions.
Antibiotics to treat chronic lung infections.
Steroids to reduce airway inflammation.
Pancreatic enzyme supplementation with all
meals and snacks to improve nutrient absorption.
Pulmonary strength training
CFTR modulators can be given in cases of specific
gene mutations.

If respiratory symptoms become unmanageable, a lung transplant
may be required to improve quality of life (Turcios, 2020).

Figure 1. Clinical Manifestations of Cystic Fibrosis ( Mansour, 2022).
o
o
o

Implications for Nursing Care

Often, the earliest symptoms are GI and nutritional disorders (Turcios, 2020).
15% of affected infants present with meconium ileus at birth (Turcios, 2020).
Non-pulmonary indicators for screening include electrolyte imbalance, rectal
prolapse, diabetes mellitus, recurrent pancreatitis, digital clubbing, chronic
sinusitis, nasal polyps, and biliary cirrhosis (Turcios, 2020).
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Figure 3. Pathologic process of Cystic Fibrosis (YourGenome, 2021).
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Result of a gene mutation that causes the abnormal production of cystic fibrosis
transmembrane conductance regulator (CFTCR) protein (McCance et al., 2019).
CFTCR protein is an activated chloride channel on the surface of numerous epithelial
cells (Karrar et al., 2022).
CFTCR protein regulates the movement of chloride ions and water secretion and
absorption (de Faria Poloni et al., 2021).
Channel dysfunction results in ionic imbalance, causing the secretion of thick and
dehydrated mucus and fat malabsorption (de Faria Poloni et al., 2021).
Abnormal epithelial fluid absorption in the lungs raises the osmotic pressure in the
mucus layer compared to the periciliary layer causing hyper-concentrated mucus
build-up in small airways (Turcios, 2020).
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Figure 2. Diagnostic Pathway of Cystic Fibrosis (Farrell et al., 2017).
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Viscous secretions contribute to mucus plugging, poor secretion mobilization, and
possibly eventual respiratory failure (May et al., 2019).
Increased accumulation of mucus and decreased mucociliary clearance facilitate
colonization by organisms, especially bacteria, resulting in recurrent respiratory
infections (Karrar et al., 2022).
The most common bacterial colonizations are pseudomonas, Haemophilus
influenza, and staphylococcus aureus (Karrar et al., 2022).
Endobronchial infection induces a hypersensitive
inflammatory response characterized by elevated levels of neutrophil elastase in the
airway that contribute to excess mucus adhesion and tenacity (Turcios, 2020).
An exaggerated inflammatory response can result in damage to the structural
integrity of the airways and the development of irreversible abnormal dilatation of
affected segmental and subsegmental bronchi (Turcios, 2020).
CF lung disease is progressive, and dysfunction leads to increased work of
breathing, impaired gas exchange progressing to arterial hypoxemia, and
eventually respiratory failure (Turcios, 2020).
Destruction of acinar pancreatic tissue, lack of enzyme activity, and pancreatic
duct obstruction result in malabsorption of fats and proteins (Turcios, 2020).

o

Conclusions
o

o
o
o

o

o

Cystic Fibrosis is a complex disease
process caused by a gene mutation
resulting in defective chloride channel
transport (Turcios, 2020).
CF affects a wide variety of body systems
(Mansour, 2022).
There is no cure for CF (Keogh et al.,
2019).
Treatment is multimodal and
progressive (Cystic Fibrosis Foundation,
n.d.).
Preventing respiratory infections is
crucial to preserving lung functionality
(Karrar et al., 2022).
Management of patients with CF would
improve with increased understanding
of the pathophysiological process and
commitment to diligent infection
prevention from healthcare
professionals.

References

Symptoms such as pancreatic enzyme deficiency, reduced
nutritional absorption, increased work of breathing and
inadequate nutrient intake all contribute to poor growth,
suboptimal clinical outcomes, and reduced life expectancy
(McCance et al., 2019).
Oral pancreatic enzyme replacement with every meal and
snack is crucial in maintaining nutritional status (McCance et
al., 2019).
Infection prevention is paramount to decreasing the incidence
of lung infections, preserving healthy lung tissue, and
maintaining airway integrity (Turcios, 2020).
Knowledge of the pathophysiologic process could result in
more appropriate intervention selection for managing
symptoms such as acute respiratory distress.

Considerations for Anesthesia
o

o

o

The extent of pulmonary involvement is the primary
determinant of appropriateness for surgery (Elisha et al.,
2023).
Patients should be evaluated several days prior to scheduled
surgery, and patients experiencing symptomatic respiratory
distress should be treated in an inpatient setting where
appropriate hydration and respiratory management can be
administered (Elisha et al., 2023).
Patients who are appropriate for surgery may still present
complications for perioperative care, including alterations in
ventilation-perfusion ratios, intrapulmonary shunting, mucous
plugging, and increased dead space (May et al., 2019).
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